Nykode Therapeutics AS

BATS-CHIXE:NYKDO Stock Report

Market Cap: NOK 5.8b

Nykode Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

BATS-CHIXE:NYKDO Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
08 Nov 24BuyNOK 9,585,978Norda ASACompany5,000,000NOK 1.92
08 Nov 24BuyNOK 9,585,978Norda ASACompany5,000,000NOK 1.92
21 Aug 24BuyNOK 282,500Alf Gunnar NicklassonIndividual50,000NOK 5.65
26 Mar 24BuyNOK 374,248Bernd SeizingerIndividual25,000NOK 14.97
21 Mar 24BuyNOK 310,271Birgitte VolckIndividual20,311NOK 15.28
13 Mar 24BuyNOK 139,969Harald GurvinIndividual10,000NOK 14.00
08 Mar 24BuyNOK 370,250Bernd SeizingerIndividual25,000NOK 14.81
08 Mar 24BuyNOK 552,400Alf Gunnar NicklassonIndividual40,000NOK 13.81
04 Mar 24BuyNOK 331,832Harald GurvinIndividual20,000NOK 16.59
29 Feb 24BuyNOK 100,260Michael EngsigIndividual6,000NOK 16.71

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of NYKDO?
Owner TypeNumber of SharesOwnership Percentage
Public Companies7,996,7552.45%
VC/PE Firms24,057,0007.37%
Institutions41,857,15612.8%
Individual Insiders56,196,25717.2%
Private Companies91,665,60728.1%
General Public104,773,66932.1%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 10.5%.

Top Shareholders

Top 25 shareholders own 64.54% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
12.5%
Jan Haudemann-Andersen
40,689,050NOK 716.5m0%no data
10.6%
Rasmussengruppen AS
34,680,750NOK 610.7m0%no data
7.37%
RADFORSK
24,057,000NOK 423.6m0%62.02%
5.28%
Victoria India Fund AS
17,255,175NOK 303.9m0%no data
3.67%
Capital Research and Management Company
12,000,000NOK 211.3m0%no data
2.6%
DNB Asset Management AS
8,493,834NOK 149.6m0%0.05%
2.45%
Norda ASA
7,996,755NOK 140.8m0%no data
2.28%
Vatne Capital AS
7,450,000NOK 131.2m0%no data
2.12%
Joh Johannson Eiendom AS
6,937,641NOK 122.2m0%no data
2%
Om Holding As
6,519,525NOK 114.8m0%no data
1.65%
Tore Voldberg
5,397,604NOK 95.1m1.22%no data
1.61%
Simen Thorsen
5,272,308NOK 92.8m-6.06%no data
1.37%
Krag Invest As
4,470,100NOK 78.7m0%no data
1.13%
Alden AS
3,702,500NOK 65.2m-0.8%no data
0.94%
AS Kassiopeia
3,075,000NOK 54.2m0%no data
0.92%
Borgano AS
3,000,000NOK 52.8m0%no data
0.74%
Danske Capital AB
2,402,000NOK 42.3m0%0.38%
0.73%
Lani Invest As
2,399,916NOK 42.3m0%no data
0.73%
Northern Trust Global Investments
2,383,699NOK 42.0m2.07%no data
0.69%
KLP Kapitalforvaltning AS
2,253,346NOK 39.7m0%0.02%
0.67%
SP Capital 22 AS
2,175,000NOK 38.3m0%no data
0.66%
Pareto Asset Management AS
2,160,842NOK 38.1m0%0.26%
0.64%
Sarsia Management AS
2,106,000NOK 37.1m0%93.11%
0.64%
Christian Åbyholm
2,105,295NOK 37.1m0%no data
0.54%
Einar Greve
1,775,000NOK 31.3m0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/02/06 00:08
End of Day Share Price 2023/11/09 00:00
Earnings2023/09/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Nykode Therapeutics AS is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Viktor SundbergABG Sundal Collier Sponsored
Geir HolomDNB Markets
Patrick TrucchioH.C. Wainwright & Co.